Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I.
about
Advances in HIV microbicide developmentThe regulation of inflammatory pathways and infectious disease of the cervix by seminal fluidPotential mechanisms for increased HIV-1 transmission across the endocervical epithelium during C. trachomatis infection.Overview of microbicides for the prevention of human immunodeficiency virus.Oral and vaginal epithelial cell lines bind and transfer cell-free infectious HIV-1 to permissive cells but are not productively infected.Uterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cellsPharmacokinetics of antiretrovirals in genital secretions and anatomic sites of HIV transmission: implications for HIV prevention.Detection of intraepithelial and stromal Langerin and CCR5 positive cells in the human endometrium: potential targets for HIV infection.In situ distribution of HIV-binding CCR5 and C-type lectin receptors in the human endocervical mucosa.Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide.Menstrual blood as a potential source of endometrial derived CD3+ T cells.Preventing HIV infection in women: a global health imperative.HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells.Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implicationsAssessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial.Selective transmission of R5 HIV-1 variants: where is the gatekeeper?HIV-1 infection of human penile explant tissue and protection by candidate microbicides.Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogensHIV-1 RNA rectal shedding is reduced in men with low plasma HIV-1 RNA viral loads and is not enhanced by sexually transmitted bacterial infections of the rectum.Progesterone-based intrauterine device use is associated with a thinner apical layer of the human ectocervical epithelium and a lower ZO-1 mRNA expression.Optical coherence tomography compared with colposcopy for assessment of vaginal epithelial damage: a randomized controlled trial.Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epitheliaHIV-1 vaginal transmission: cell-free or cell-associated virus?Tonsil epithelial factors may influence oropharyngeal human immunodeficiency virus transmission.Biological factors that place women at risk for HIV: evidence from a large-scale clinical trial in Durban.Modulation of hepatocyte growth factor secretion in human female reproductive tract stromal fibroblasts by poly (I:C) and estradiolVisualization of X4- and R5-Tropic HIV-1 Viruses Expressing Fluorescent Proteins in Human Endometrial Cells: Application to Tropism Study.Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue.Innate and adaptive anti-HIV immune responses in the female reproductive tract.Estradiol selectively regulates innate immune function by polarized human uterine epithelial cells in cultureA systems biology examination of the human female genital tract shows compartmentalization of immune factor expression.Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy WomenSetting the stage: host invasion by HIV.A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle.Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens.Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative women.Nanoparticles containing siRNA to silence CD4 and CCR5 reduce expression of these receptors and inhibit HIV-1 infection in human female reproductive tract tissue explants.Current and future microbicide approaches aimed at preventing HIV infection in women.Influence of common mucosal co-factors on HIV infection in the female genital tract.Genital schistosomiasis and its unacknowledged role on HIV transmission in the STD intervention studies.
P2860
Q26852858-FB0563FD-41CB-410B-B6DE-BC32AD585CBCQ27024447-02E2A4F4-C74B-4017-83E3-2F2958239A70Q30413754-95AB888B-16CD-4DFB-B207-60C8768901CEQ30413777-A52CB496-303B-4B19-BC02-15F424222E17Q33654841-CEE80022-0201-4B3E-989D-FBCA1FB11F31Q33778508-0AA824E9-F658-4901-8115-B9901A2D2D95Q33888718-C00B7728-E7A9-489A-A604-B984771096B8Q33954795-9BCC01D2-ECA1-4ADD-9435-C4B77CA5D3D0Q34044944-133A5C3D-7210-4A3A-9D74-C4DA989BBC48Q34059103-C21FB86B-7EAD-4E17-8114-FFADC4E01BC5Q34103466-D69BDA70-BDFB-418C-A03C-E970A2A059EEQ34495248-78CDAE71-B1FA-49BE-8BFB-BACA9B98D74FQ34554611-D8EABBF3-2CA7-41BE-9CC1-FACCB0ED3171Q34712244-8D0A6FB8-EA76-47DC-BDEC-792DF3ECA993Q34991650-70119D36-C10B-466F-86B6-A2D33D2E0314Q35018140-6E573624-0C18-4B6D-B068-5626714C7C6CQ35148241-02237F70-8F83-4DFA-93C3-6649FD27DB44Q35153994-5EBACEA5-D471-4681-B4EA-0152CF0BFEA4Q35164471-1F8AD06E-8E49-4C54-8C73-A72079111B60Q35172396-DCD0E1C0-B528-4A9C-8745-822CAB3515D0Q35633776-38AFC927-850F-4E01-B312-05E63AD828DDQ35826167-A970CB1B-93F5-42DC-A74E-6AC73083D070Q35897398-EB5C4391-00AA-4580-BF8A-232B8157688CQ35916009-510D12FB-0176-4198-B0FE-2C1FD40BF69BQ35963220-F5F87736-B27E-41E8-85C5-62A082E2C294Q36238722-3C9B3B06-45C4-44D2-A65E-36F2BBF2DB25Q36242730-7B425C89-1832-4A0F-B8A8-1551800C147CQ36325778-FA42F002-0311-45A1-AD5D-5A8644DDC4B9Q36637034-D2E0E6F7-D640-41BF-BCAA-6AE1A243EF0AQ36751036-41AB53FC-6A26-4EFA-95DE-69AD3903BD7CQ36759980-EFE6C9C5-782B-42C1-ADDA-AF7EBD2746FEQ36966645-A6371FEE-2454-446B-BB6E-9A215F863DB8Q36983857-04E180E5-4896-40CF-B8D9-EDA483BC8478Q37108089-E0613D8D-1863-465A-B534-697C931625E3Q37334338-ACAF675B-C883-4543-8784-B9D5BB4F3D24Q37362444-0CA5EDBA-8A8F-44FE-9DD0-A195BBB619B5Q37481839-FC10E190-CEDB-4C8A-8F65-408B1B38A08AQ37984498-0F390566-59CD-49FC-961C-E6584482888EQ38195075-F7FE292C-B614-45AC-AD96-BDAF9732A777Q38195365-1D169B29-C287-45E1-B085-20BA10FE964F
P2860
Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Chemokine receptor expression ...... immunodeficiency virus-type I.
@en
type
label
Chemokine receptor expression ...... immunodeficiency virus-type I.
@en
prefLabel
Chemokine receptor expression ...... immunodeficiency virus-type I.
@en
P2093
P2860
P1433
P1476
Chemokine receptor expression ...... immunodeficiency virus-type I.
@en
P2093
Alexandra L Howell
Charles R Wira
Douglas J Demian
Grant R Yeaman
Jane E Collins
Jorge L Gonzalez
Michael W Fanger
Sally Weldon
Susana Asin
P2860
P304
P356
10.1111/J.1365-2567.2004.01990.X
P577
2004-12-01T00:00:00Z